Benicar and Pregnancy: An Overview
For people who are pregnant,
Benicar® (
olmesartan medoxomil) is usually not recommended. This is because during pregnancy, Benicar can cause temporary or permanent problems, including death, to the unborn child.
Benicar and Pregnancy: What Is the Risk?
Prior to 2006, there was a common belief among healthcare providers that problems with Benicar and pregnancy were generally seen when the drug was taken during the second or
third trimester. However, that changed when a study by researchers at Vanderbilt University was published in the June 2006 edition of the
New England Journal of Medicine. This study showed that there may, in fact, also be an increased risk to the fetus if it is exposed to drugs like Benicar during the
first trimester. Whether the risk to the fetus is as great in the first trimester as in the second or third trimester is not known.
Some of the complications seen with fetuses or newborns exposed to Benicar during pregnancy include:
- Low blood pressure (hypotension)
- Developmental problems with the nervous system
- Developmental problems with the cardiovascular system (this includes the heart and/or blood vessels)
- Developmental problems with the lungs
- Kidney failure
- Deformities of the head and face
- Loss of life.